Nykode Therapeutics Stock
Stocks
VACC
NO0010714785
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Oslo Bors
10:45:00 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 3.385 NOK | -1.46% |
|
+1.65% | +40.34% |
| 08-06 | Nykode Therapeutics Asa Announces Appointment of Jakob Helding Rasmussen as Chief Technology Officer | CI |
| 08-04 | Nykode Therapeutics Flags Delay in Draft Recommendation for Tax Appeal in Norway | MT |
| Market Cap | 1.11B 117M 101M 95.04M 86.43M 162M 11.2B 165M 1.11B 435M 5.61B 440M 430M 18.63B | P/E 2026 * |
-5.24x | P/E 2027 * | -36.6x |
|---|---|---|---|---|---|
| Enterprise Value | 620M 65.71M 56.75M 53.33M 48.5M 91.18M 6.28B 92.68M 625M 244M 3.15B 247M 241M 10.46B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 3.26x |
| Free-Float |
56.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Nykode Therapeutics
| 1 day | -1.46% | ||
| 1 week | +1.65% | ||
| Current month | +0.15% | ||
| 1 month | +21.54% | ||
| 3 months | +9.55% | ||
| 6 months | -10.45% | ||
| Current year | +40.34% |
| 1 week | 3.24 |  | 3.48 |
| 1 month | 2.66 | | 3.56 |
| Current year | 2.21 | | 4.1 |
| 1 year | 1.44 | | 4.1 |
| 3 years | 1.44 | | 30.18 |
| 5 years | 1.44 | | 85.3 |
| 10 years | 1.44 | | 93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Engsig
CEO | Chief Executive Officer | 54 | 2018-12-31 |
| President | 49 | 2016-12-31 | |
Harald Gurvin
DFI | Director of Finance/CFO | 51 | 2021-05-02 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | - | |
Trygve Lauvdal
BRD | Director/Board Member | 57 | - |
Susanne Stuffers
CHM | Chairman | 45 | 2025-04-22 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/27/25 | Buy | Company | 3,000,000 | 0.9187% | ||
| 12/20/24 | Buy | Director | 100,000 | 0.0306% | ||
| 12/20/24 | Sell | Director | 100,000 | 0.0306% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.46% | +1.65% | +96.69% | -88.44% | 117M | |
| -1.90% | +2.85% | +62.82% | +104.13% | 70.07B | |
| -3.21% | -4.32% | +31.85% | +57.27% | 52.87B | |
| -2.05% | -5.61% | -3.18% | +449.71% | 27.02B | |
| -1.27% | -1.57% | +45.90% | +8.25% | 23.61B | |
| +1.05% | -0.62% | -18.00% | -11.93% | 23.38B | |
| +3.81% | +20.97% | +266.37% | +531.28% | 19.43B | |
| +0.10% | +1.40% | +35.36% | -19.94% | 18.75B | |
| -0.95% | -3.52% | +19.93% | +594.00% | 15.85B | |
| +1.24% | -5.23% | +33.75% | +137.66% | 12.7B | |
| Average | -0.46% | +2.42% | +57.15% | +176.20% | 26.38B | |
| Weighted average by Cap. | -1.09% | +0.56% | +50.25% | +164.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 162M 17.13M 14.79M 13.9M 12.64M 23.77M 1.64B 24.16M 163M 63.69M 820M 64.31M 62.92M 2.73B |
| Net income | -208M -22.02M -19.02M -17.87M -16.26M -30.56M -2.11B -31.07M -209M -81.89M -1.05B -82.69M -80.89M -3.5B | -41.58M -4.4M -3.8M -3.57M -3.25M -6.11M -421M -6.21M -41.89M -16.38M -211M -16.54M -16.18M -701M |
| Net Debt | -485M -51.39M -44.38M -41.71M -37.93M -71.31M -4.91B -72.49M -489M -191M -2.46B -193M -189M -8.18B | -578M -61.18M -52.84M -49.65M -45.16M -84.9M -5.85B -86.3M -582M -227M -2.93B -230M -225M -9.73B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | NOK 3.385 | -1.46% | 315,985 |
| 26-08-13 | NOK 3.435 | +1.63% | 385,325 |
| 26-08-12 | NOK 3.380 | +2.74% | 623,612 |
| 26-08-11 | NOK 3.290 | -0.30% | 220,292 |
| 26-08-10 | NOK 3.300 | -0.90% | 341,054 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VACC Stock
Select your edition
All financial news and data tailored to specific country editions
